NexGard® is a flea and tick prevention medication for dogs that was developed by Boehringer Ingelheim ... Minnesota, New Jersey, and Puerto Rico. They make up the second-largest animal health company ...

Boehringer Ingelheim will conduct biophysical and structural studies, including cryo-electron microscopy (cryoEM), on Boehringer pipeline targets enabled by the Salipro®-technology to identify ...

Ingelheim, Germany, 20 February 2025 – Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)1 and OXB,1 today announce the start of LENTICLAIRTM 1, a Phase I/II trial ...

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. VAXXITEK® HVT ...

They compared an original set of prints taken in Puerto Rico in 1986, the year before Milla-Valdes fled incarceration, with another set collected by authorities in South Florida's Monroe County ...

(Image Credits: Pixabay) Boehringer Ingelheim’s blockbuster diabetes drug, Empagliflozin, is now off-patent in India, paving the way for domestic drugmakers to launch generic versions.

Jorge Milla-Valdes escaped from a Puerto Rican prison in 1987. The Puerto Rico Department of Justice believed he was living under the name Luis Aguirre. His criminal history included robbery and ...

Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

I think it’s called Puerto Rico,” he said onstage. “I welcome migrants to the United States with open arms, and by open arms, I mean like this,” he said, with hand gestures signaling “no ...

Credit: Tapati Rinchumrus/Shutterstock. Boehringer Ingelheim and Sweden-based Salipro Biotech have entered a research and licence agreement to expedite the development of several drug targets. The ...